Effectiveness and Safety of the Dexcom G6 Continuous Glucose Monitoring System in Non-Critically Ill Patients in the Inpatient Setting

Exclusion Criteria

• •Presence of extensive skin changes/diseases at sensor wear site(s) that preclude wearing the sensor(s) on normal skin (e.g., extensive psoriasis, recent burns or severe sunburn, extensive eczema, extensive scarring, extensive tattoos, dermatitis herpetiformis)
• •Currently in an intensive care unit (ICU) of the following type (does not apply to participants placed in an ICU bed due to space issues in the non-ICU areas)
• •Known allergy to medical-grade adhesives
• •Pregnancy, demonstrated by a positive test (for subjects of childbearing potential)
• •Women admitted to give birth or any other admission related to pregnancy
• •Patients receiving Hydroxyurea
• •Bleeding disorder
• •Participants that are currently being treated for malignancies, cancer
• •Participant that are hospitalized to receive an organ transplant
• •Require a Magnetic Resonance Imaging (MRI) scan
• •End stage renal disease and currently managed by dialysis or anticipating initiating dialysis during the study wear period
• •Current participation in another investigational study protocol (If a subject has recently completed participation in another drug study, the subject must have completed that study at least 7 days prior to being enrolled in this study.)
• •Any condition that, in the opinion of the Investigator, would interfere with their participation in the trial or pose an excessive risk to study staff (e.g., known history of hepatitis B or C)